Search
for
Sort by
Research 241–270 of 1000+
- Emerging treatments in alopecia
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- LUPUS ERYTHEMATOSUS AND THE SKIN
- The Invisible Threat to Hair and Scalpfrom Air Pollution
- In vivo and in vitro studies of anti-aging properties of Dendrobium sabin flower
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Oxidative Modification in Human Hair: The Effect of the Levels of Cu (II) Ions, UV Exposure and Hair Pigmentation
- Psychoactive drugs and skin
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Dermatology and Pregnancy
- Scarring Alopecia
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Nonscarring Alopecias
- Psoriasis
- Atypical fibroxanthoma of the scalp following hair transplantation in a 35-year-old male
- Vitamin D and the skin: Focus on a complex relationship: A review
- Coffee Silverskin: A Review on Potential Cosmetic Applications
- Signaling pathways in hair aging
- Parkinson's disease and skin
- A Comprehensive Review of Current Anti-Aging Mechanisms and Therapeutic Approaches
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Hair follicle organoids: advances in construction, applications, and translational challenges
- Functional Applications of Nanomaterials in Plastic Surgery: Strategies, Practice and Evaluation
- Hormone replacement therapy and the skin
- An Investigation of Hair and its Keratin Associated Proteins using Advanced Light Microscopy
- Alopecia areata
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients